GAM Holding’s AEON Biopharma AEON Stock Holding History

GAM Holding’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-465	Closed	-$328K	–	254
2022 Q1	$328K	Hold	465	–	–	0.02%	257
2021 Q4	$325K	Buy	+465	New	+$327K	0.01%	286

Other funds holding AEON

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GAM Holding's AEON Position: Q2 2022 in Review

GAM Holding sold out of AEON Biopharma (AEON) in Q2 2022, closing a stake of 465 shares — an estimated $328K sold.

GAM Holding first reported a position in AEON in Q4 2021 and held it in 2 quarters. The position peaked at $328K in Q1 2022. 73 funds tracked by Wall St. Rank hold AEON as of Q2 2022.

GAM Holding reported no remaining AEON Biopharma position as of Q2 2022 after selling out during the quarter.
GAM Holding sold 465 AEON Biopharma shares in Q2 2022, an estimated $328K.
GAM Holding first reported a position in AEON Biopharma in Q4 2021 and held it in 2 quarters.
GAM Holding's AEON Biopharma position peaked at $328K in Q1 2022.
73 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2022.

Based on GAM Holding's 13F filing for Q2 2022, filed 21 Jul 2022.